{"nct_id":"NCT06049212","title":"Sacituzumab Tirumotecan (MK-2870) as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors (MK-2870-008)","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2023-10-26","start_date_type":"ACTUAL","primary_completion_date":"2026-06-30","primary_completion_date_type":"ESTIMATED","completion_date":"2027-01-29","completion_date_type":"ESTIMATED","phases":["PHASE1"],"tickers":["MRK"]}